Summary
Nerve growth factor (NGF) induces neurite outgrowth and promotes survival of embryonic sensory and sympathetic neurons. TRKA, a receptor tyrosine kinase cloned from a human colon cancer was later found to be expressed in the nervous system and phosphorylated in response to NGF. Somatic rearrangement(s) of theTRKA gene (also designatedNTRK1) are responsible for formation of some oncogenes. Genetic defects in TRKA are responsible for a human disorder, congenital insensitivity to pain with anhidrosis (CIPA). We report here isolation and characterization of theTRKA gene which spans at least 23 kb and is split into 17 exons. Exon sizes range from 18 to 394 bp and intron sizes range from 170 bp to at least 3.3 kb. Sizes and boundaries of the exons were determined, and all the splice donor and acceptor sites conformed to the GT/AG rule. Approximately 1.2 kb of the 5′-flanking regions was sequenced, and putative regulatory elements were identified. These results will be useful for studies on the developmental and biological regulation of theTRKA gene and for further characterization of mutations in CIPA patients as well as elucidation of mechanisms responsible for rearrangement(s) observed in human tumors.
Article PDF
References
Baeuerle PA, Henkel T (1994): Function and activation of NF-κB in the immune system. Annu Rev Immunol12: 141–179
Barbacid M (1995): Structural and functional properties of the TRK family of neurotrophin receptors. Ann NY Acad Sci766: 442–458
Barker PA, Lomen HC, Gensch EM, Meakin SO, Glass DJ, Shooter EM (1993): Tissue-specific alternative splicing generates two isoforms of thetrkA receptor. J Biol Chem268: 15150–15157
Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borrello MG, Pierotti MA (1995): A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics28: 15–24
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996): A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature380: 152–154
Dikic I, Batzer AG, Blaikie P, Obermeier A, Ullrich A, Schlessinger J, Margolis B (1995): Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J Biol Chem270: 15125–15129
Dyck PJ (1984): Neuronal atrophy and degeneration predominantly affecting sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds). Peripheral neuropathy. W.B. Saunders, Philadelphia, pp 1557–1599
Faisst S, Meyer S (1992): Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res20: 23–26
Frumkin A, Haffner R, Shapira E, Tarcic N, Gruenbaum Y, Fainsod A (1993): The chickenCdxA homeobox gene and axial positioning during gastrulation. Development118: 553–562
Greco A, Mariani C, Miranda C, Pagliardini S, Pierotti MA (1993): Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes. Genomics18: 397–400
Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, Pierotti MA (1995): The DNA rearrangement that generates theTRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol15: 6118–6127
Harada R, Berube G, Tamplin OJ, Denis LC, Nepveu A (1995): DNA-binding specificity of the cut repeats from the human cut-like protein. Mol Cell Biol15: 129–140
Indo Y, Tsuruta M, Hayashida Y, Karim MA, Ohta K, Kawano T, Mitsubuchi H, Tonoki H, Awaya Y, Matsuda I (1996): Mutations in theTRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nature Genet13: 485–488
Kaplan DR, Hempstead BL, Martin ZD, Chao MV, Parada LF (1991): The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science252: 554–558
Klein R, Jing SQ, Nanduri V, O’Rourke E, Barbacid M (1991): The trk proto-oncogene encodes a receptor for nerve growth factor. Cell65: 189–197
Kozma SC, Redmond SM, Fu XC, Saurer SM, Groner B, Hynes NE (1988): Activation of the receptor kinase domain of thetrk oncogene by recombination with two different cellular sequences. EMBO J7: 147–154
Kroeger PE, Morimoto RI (1994): Selection of new HSF1 and HSF2 DNA-binding sites reveals difference in trimer cooperativity. Mol Cell Biol14: 7592–7603
Kunsch C, Ruben SM, Rosen CA (1992): Selection of optimalκ/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol12: 4412–4421
Levi-Montalcini R (1987): The nerve growth factor: thirty-five years later. EMBO J6: 1145–1154
Loeb DM, Stephens RM, Copeland T, Kaplan DR, Greene LA (1994): A Trk nerve growth factor (NGF) receptor point mutation affecting interaction with phospholipase C-γ1 abolishes NGF-promoted peripherin induction but not neurite outgrowth. J Biol Chem269: 8901–8910
Margalit Y, Yarus S, Shapira E, Gruenbaum Y, Fainsod A (1993): Isolation and characterization of target sequences of the chicken CdxA homeobox gene. Nucleic Acids Res21: 4915–4922
Martin-Zanca D, Hughes SH, Barbacid M (1986): A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature319: 743–748
Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M (1989): Molecular and biochemical characterization of the humantrk proto-oncogene. Mol Cell Biol9: 24–33
Martin-Zanca D, Barbacid M, Parada LF (1990): Expression of thetrk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Dev4: 683–694
McKusick VA (1994): Mendelian inheritance in man. The Johns Hopkins University Press, Baltimore
Meakin SO, Suter U, Drinkwater CC, Welcher AA, Shooter EM (1992): The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc Natl Acad Sci USA89: 2374–2378
Miozzo M, Pierotti MA, Sozzi G, Radice P, Bongarzone I, Spurr NK, Della PG (1990): Human TRK proto-oncogene maps to chromosome 1q32–q41. Oncogene5: 1411–1414
Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R (1991): Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev5: 105–119
Morris CM, Hao QL, Heisterkamp N, Fitzgerald PH, Groffen J (1991): Localization of the TRK proto-oncogene to human chromosome bands 1q23–1q24. Oncogene6: 1093–1095
Nakagawara A, Liu XG, Ikegaki N, White PS, Yamashiro DJ, Nycum LM, Biegel JA, Brodeur GM (1995): Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2). Genomics25: 538–546
Neufeld EJ, Skalnik DG, Lievens PM, Orkin SH (1992): Human CCAAT displacement protein is homologous to theDrosophila homeoprotein, cut. Nature Genet1: 50–55
Obermeier A, Lammers R, Wiesmuller KH, Jung G, Schlessinger J, Ullrich A (1993a): Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J Biol Chem268: 22963–22966
Obermeier A, Halfter H, Wiesmuller KH, Jung G, Schlessinger J, Ullrich A (1993b): Tyrosine 785 is a major determinant of Trk-substrate interaction. EMBO J12: 933–941
Obermeier A, Bradshaw RA, Seedorf K, Choidas A, Schlessinger J, Ullrich A (1994): Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC andγ. EMBO J13: 1585–1590
Schmidt UR, Memet S, Lilienbaum A, Feuillard J, Raphael M, Israel A (1996): NF-κB activity in transgenic mice: developmental regulation and tissue specificity. Development122: 2117–2128
Shapiro MB, Senapathy P (1987): RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res15: 7155–7174
Snider WD (1994): Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell77: 627–638
Soltoff SP, Rabin SL, Cantley LC, Kaplan DR (1992): Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J Biol Chem267: 17472–17477
Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR (1994): Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ1 to mediate NGF responses. Neuron12: 691–705
Swanson AG (1963): Congenital insensitivity to pain with anhidrosis. Arch Neurol8: 299–306
Thoenen H, Barde Y-A (1980): Physiology of nerve growth factor. Physiol Rev60: 1284–1335
Urfer R, Tsoulfas P, O’Connell L, Shelton DL, Parada LF, Presta LG (1995): An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J14: 2795–2805
Wingender E (1994): Recognition of regulatory regions in genomic sequences. J Biotechnol35: 273–280
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Indo, Y., Mardy, S., Tsuruta, M. et al. Structure and organization of the humanTRKA gene encoding a high affinity receptor for nerve growth factor. Jap J Human Genet 42, 343–351 (1997). https://doi.org/10.1007/BF02766957
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02766957
Key Words
This article is cited by
-
Clinical, genomics and networking analyses of a high-altitude native American Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case report
BMC Medical Genomics (2020)
-
EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
Oncogene (2018)
-
Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration
Molecular Neurobiology (2017)
-
Novel transcripts reveal a complex structure of the human TRKA gene and imply the presence of multiple protein isoforms
BMC Neuroscience (2015)
-
Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression
Oncogene (2005)